GlaxoSmithKline management on the open offer for GSK Pharma
PUBLISHED ON: December 16, 2013 | Duration: 3 min, 20 sec
David Redfern, chief strategy officer at GlaxoSmithKline speaks to NDTV about the Rs 6,400 crore open offer for GSK Pharma and the reasons behind the company's decision to up its stake in its India unit.
